Physician profile
Richard Borge
NPI 1205820867
$169,620.04
in general payments reported to CMS, 2019-2025
37 companies · $1,671 in 2025
The $1,671 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $72K · 2020: $13K · 2021: $29K · 2022: $22K · 2023: $15K · 2024: $16K · 2025: $1,671.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $26K · Food and Beverage: $5,768 · Travel and Lodging: $1,111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $26,090.00 |
| Food and Beverage | $5,768.30 |
| Travel and Lodging | $1,110.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $57,626.12 | 2019-2024 | Xarelto |
| Biotronik INC. | $35,301.50 | 2019-2025 | Biomonitor, Amvia Edge, Renamic Neo |
| Pfizer INC. | $23,739.57 | 2019-2025 | |
| Cardiofocus, INC. | $23,192.19 | 2019-2023 | Heartlight System |
| E.R. Squibb & Sons, L.L.C. | $13,427.40 | 2019-2025 | Camzyos, Eliquis |
| Boston Scientific Corporation | $6,378.15 | 2019-2025 | Watchman Access System, General - Therapies, Watchman |
| Abbott Laboratories | $6,161.11 | 2019-2024 | Ensite, Ensite Precision, Gallant |
| Biosense Webster, INC. | $574.50 | 2022-2025 | Carto 3, Nuvision Ice Catheter, Qdot Micro Catheter |
| Medtronic, INC. | $526.72 | 2022 | |
| Amgen INC. | $446.25 | 2019-2025 | Repatha |
| Novartis Pharmaceuticals Corporation | $427.05 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $302.64 | 2019-2025 | Farxiga, Brilinta |
| Atricure, INC. | $209.18 | 2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $145.75 | 2019-2020 | |
| Acutus Medical, INC. | $134.08 | 2021-2022 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $110.03 | 2019-2023 | |
| Abiomed | $106.31 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $97.90 | 2019-2025 | Jardiance |
| Lexicon Pharmaceuticals, INC. | $83.31 | 2023-2024 | Inpefa |
| Merck Sharp & Dohme LLC | $68.04 | 2022-2025 | Verquvo |
| Novo Nordisk INC | $60.12 | 2025 | Wegovy |
| Impulse Dynamics (USA) INC. | $55.70 | 2024 | Optimizer |
| Amarin Pharma, INC. | $51.58 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $51.00 | 2023-2024 | Opsumit, Uptravi |
| Lilly USA, LLC | $41.49 | 2025 | Zepbound, Mounjaro |
| Preventice Services, LLC | $37.46 | 2019 | |
| Infobionic, INC | $35.74 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $30.25 | 2023 | Arcalyst |
| Philips North America LLC | $27.02 | 2024 | (Ao0) Igt Devices Intracardiac |
| Terumo Medical Corporation | $24.42 | 2019-2020 | |
| Medtronic Vascular, INC. | $23.79 | 2019 | |
| Lundbeck LLC | $23.62 | 2019 | |
| Vital Connect, INC | $22.57 | 2025 | Vitalpatch Rtm |
| Endotronix, INC. | $22.53 | 2024 | Cordella Pulomonary Artery Pressure Sensor |
| Glaxosmithkline, LLC. | $20.34 | 2025 | Shingrix, Arexvy |
| Inspire Medical Systems, INC. | $17.95 | 2025 | Inspire |
| Medicomp INC | $16.66 | 2025 | Telepatch Cardiac Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Borge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.